WiQo Moisturizing Face Cream 50 ml I Dry Skin

WiQo Moisturizing Face Cream for Dry Skin is classed as a class III medical device, so the label can highlight a “nutrient-rich, protective formula” without revealing precise numbers. What counts is how the blend behaves like a breathable “liquid dressing.” Occlusives—plant butters and medical-grade silicones—slow transepidermal water loss (TEWL). Humectants draw moisture from the air to the skin’s outer layer, while emollients slip between cells so the surface feels supple instead of flaky. Together they calm redness and itching, shorten the inflammatory phase, and cut the risk of post-peel dark spots. Every WiQo batch bears the CE mark and meets strict EU limits on preservatives and leachables, giving even sensitised skin a safety net. The finish feels velvety, not greasy, so daytime wear stays comfortable.

The cream is the very next step after PRX-T33 or similar biorevitalisation peels. Right after a peel, the epidermis struggles to hold water; without fast help, patients feel sting, redness, and tightness. A twice-daily layer of WiQo replaces lost lipids, eases micro-inflammation, and keeps normal shedding on track so collagen rebuilding is not delayed. Beyond peel recovery, it suits chronically dry or mature skin, atopic tendencies, retinoid users, and anyone in low-humidity climates. Antioxidant vitamins mop up peel-generated free radicals, and the non-comedogenic base avoids milia on neck and chest. Compared with hyaluronic-heavy creams that plump, WiQo trades volume for a stronger barrier—great for comfort seekers. Oil-prone clients can later switch to the Normal/Combination version.

Each retail unit is a 50 ml air-less pump tube sealed with a tamper label and printed lot/expiry codes for full EU traceability. The outer carton repeats the CE mark and class-III pictogram and holds a multilingual leaflet with patch-test advice, twice-daily routine, and storage below 25 °C. A peel-and-stick batch label is ready for clinic files, handy when documenting combination treatments. A small clip locks the pump so it won’t leak in a travel bag. Because the formula is strictly topical, no needles or sharps are involved, keeping disposal simple.

Most patients feel relief for twelve to twenty-four hours after one application, matching the morning-and-evening routine in the insert. Corneometry tests on similar shea-rich creams show skin hydration climbs by at least thirty-five percent within thirty minutes and stays above baseline eight hours later. Clinics often schedule a check-up two weeks post-peel and another at six weeks; many people keep using the cream once daily through winter or during retinoid cycles. If you stop, TEWL creeps back to pre-cream levels within three days—proof the barrier benefits rely on steady use.

Q1: Can I layer sunscreen over WiQo?
A1: Yes. Apply the cream first, wait five minutes, then add a broad-spectrum SPF. The semi-occlusive film plays nicely with most mineral sunscreens and should not pill.

Q2: Is it safe during pregnancy?
A2: The formula contains no retinoids or salicylic acid, but because it is a class III medical device, pregnant users should still check with their clinician before starting.

Q3: Why doesn’t the label list exact percentages?
A3: EU law lets device makers protect proprietary blends; only known allergens need numbers. WiQo still meets full CE traceability rules.

WiQo is produced by GPQ Srl, Via Flavia 23/1, 34138 Trieste, Italy. The company introduced glycolic-free biorevitalisation with PRX-T33 and builds its home-care range to protect procedure results. Manufacturing runs under ISO 13485, and every lot carries the “Total Traceability” CE mark. Packaging uses recyclable HDPE bottles and FSC-certified cartons; a full sustainability plan is in progress. Distribution is clinician-first across the EU, though authorised partners such as Reliable Medicare UK now serve informed consumers.